Immunify.Life and MMUST to mark World AIDS Day with a special AMA session addressing the partnership and joint efforts to fight the disease
(MMUST). Together they have secured approval from the Institutional Ethics Committee (IEC) and the National Commission for Science, Technology, and Innovation (NACOSTI) for commencing a ground-breaking 5-year study on HIV/AIDS, starting in Kakamega County, Kenya and extending to the rest of the country.
Immunify.Life and MMUST are holding a special joint AMA Session today to raise awareness about the unmet need for HIV treatment in Africa and explain the joint project. During the online conference, which is scheduled for 10 AM UTC on Twitter Spaces, Immunify.Life will be represented by CEO Guy Newing and COO Daniel Kenny. MMUST’s leading clinical investigators Drs. Tecla Sum and Bernard Wesonga will address the challenges of HIV treatment in Africa and share their HIV study design.
“This is a great opportunity for us to put our solutions to the test in the best way possible. We’re excited to see how this new technology can have humanitarian applications and help to create healthy incentives for underserved populations. We appreciate MMUST’s interest and will be working hard to make sure that the medical community at large is able to benefit from the advancements we make here in our fight against HIV.” – Immunify.Life Chief Executive Officer Guy Newing.
Next, MMUST will begin the use of Immunify.Life's solutions to collect and analyze...
